Pregled bibliografske jedinice broj: 1059821
Prothrombin 3'end Gene Variants in Patients With Sporadic Colon Adenocarcinoma
Prothrombin 3'end Gene Variants in Patients With Sporadic Colon Adenocarcinoma // Anticancer research, 39 (2019), 11; 6067-6071 doi:10.21873/anticanres.13814 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1059821 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Prothrombin 3'end Gene Variants in Patients With Sporadic Colon Adenocarcinoma
Autori
Cumbo, Marija ; Tomić, Branko ; Dunjić, Sofija ; Jovanović, Tamara ; Gvozdenov, Maja ; Pruner, Iva ; Aralica, Gorana ; Kapitanović, Sanja ; Čačev, Tamara ; Đorđević, Valentina
Izvornik
Anticancer research (0250-7005) 39
(2019), 11;
6067-6071
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
colon adenocarcinoma ; normal adjacent tissue ; prothrombin ; tumor ; 3'end gene variants
Sažetak
Background/ Aim: Thrombin plays significant roles in various types of cancer. However, the expression levels of prothrombin, the thrombin precursor, in cancer remain unclear. Variants of the 3'end of the prothrombin gene lead to increased prothrombin expression. This study aimed to analyze prothrombin 3'end gene variants in colon tumor and adjacent normal tissue samples. Materials and Methods: The study group consisted of 93 patients suffering from colon adenocarcinoma. The 3'end of the prothrombin gene was analyzed by DNA sequencing. Results: Three variants, all previously associated with increased prothrombin expression were detected. Frequency of the FII 19911G allele was 46.77% and 47.85% in tumor and normal tissue, respectively. For the FII 20210A allele, the detected frequencies were 2.15% and 1.61%, respectively. The frequency of the FII c.1824T allele was 0.54% in both tissues. Four patients showed different genotypes in tumor and normal tissue. Conclusion: Prothrombin 3' end gene variants may play a role in colorectal cancer.
Izvorni jezik
Hrvatski
Znanstvena područja
Temeljne medicinske znanosti
Napomena
Rad je rezultat suradnje na bilateralnom projektu Uloga protrombina u karcinomu debelog crijeva.
POVEZANOST RADA
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava"
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE